224 related articles for article (PubMed ID: 15823733)
1. The anti-inflammatory and antioxidant effects of long-chain n-3 fatty acids or oil-rich fish may favorably affect atrial remodeling in atrial fibrillation.
Korantzopoulos P; Kolettis TM; Goudevenos JA
Med Hypotheses; 2005; 64(6):1245-6. PubMed ID: 15823733
[No Abstract] [Full Text] [Related]
2. Anti-inflammatory and antioxidant actions of statins may favorably affect atrial remodeling in atrial fibrillation.
Korantzopoulos P; Kountouris E; Kolettis T; Siogas K
Am J Cardiol; 2004 May; 93(9):1200. PubMed ID: 15110227
[No Abstract] [Full Text] [Related]
3. Reduced incidence of vagally induced atrial fibrillation and expression levels of connexins by n-3 polyunsaturated fatty acids in dogs.
Sarrazin JF; Comeau G; Daleau P; Kingma J; Plante I; Fournier D; Molin F
J Am Coll Cardiol; 2007 Oct; 50(15):1505-12. PubMed ID: 17919572
[TBL] [Abstract][Full Text] [Related]
4. Fish oil and prevention of atrial fibrillation.
Mozaffarian D
J Am Coll Cardiol; 2007 Oct; 50(15):1513-4. PubMed ID: 17919573
[No Abstract] [Full Text] [Related]
5. Probucol attenuates atrial structural remodeling in prolonged pacing-induced atrial fibrillation in dogs.
Li Y; Sheng L; Li W; Liu W; Gong Y; Xue H; Shan H
Biochem Biophys Res Commun; 2009 Apr; 381(2):198-203. PubMed ID: 19338773
[TBL] [Abstract][Full Text] [Related]
6. Tracing the origins of postoperative atrial fibrillation: the concept of oxidative stress-mediated myocardial injury phenomenon.
Elahi MM; Flatman S; Matata BM
Eur J Cardiovasc Prev Rehabil; 2008 Dec; 15(6):735-41. PubMed ID: 19020458
[TBL] [Abstract][Full Text] [Related]
7. Fish oil for the reduction of atrial fibrillation recurrence, inflammation, and oxidative stress.
Nigam A; Talajic M; Roy D; Nattel S; Lambert J; Nozza A; Jones P; Ramprasath VR; O'Hara G; Kopecky S; Brophy JM; Tardif JC;
J Am Coll Cardiol; 2014 Oct; 64(14):1441-8. PubMed ID: 25277614
[TBL] [Abstract][Full Text] [Related]
8. Is there a role for long-chain omega3 or oil-rich fish in the treatment of atrial fibrillation?
Harrison RA; Elton PJ
Med Hypotheses; 2005; 64(1):59-63. PubMed ID: 15533612
[TBL] [Abstract][Full Text] [Related]
9. [Morphological remodeling in atrial fibrillation].
Goette A; Lendeckel U
Herz; 2006 Apr; 31(2):101-7; quiz 142-3. PubMed ID: 16738831
[TBL] [Abstract][Full Text] [Related]
10. Non-ion channel blockers as anti-arrhythmic drugs (reversal of structural remodeling).
Goette A; Bukowska A; Lendeckel U
Curr Opin Pharmacol; 2007 Apr; 7(2):219-24. PubMed ID: 17276728
[TBL] [Abstract][Full Text] [Related]
11. [Atrial remodeling and anti-remodeling therapy in atrial fibrillation].
Neumann T; Hölschermann H
Dtsch Med Wochenschr; 2006 Apr; 131(16):884-7. PubMed ID: 16625482
[No Abstract] [Full Text] [Related]
12. Omega-3 polyunsaturated fatty acids (PUFAs or fish oils) and atrial fibrillation.
Opthof T; Den Ruijter HM
Br J Pharmacol; 2007 Feb; 150(3):258-60. PubMed ID: 17179951
[No Abstract] [Full Text] [Related]
13. Atrial structural remodeling as an antiarrhythmic target.
Burstein B; Nattel S
J Cardiovasc Pharmacol; 2008 Jul; 52(1):4-10. PubMed ID: 18594481
[TBL] [Abstract][Full Text] [Related]
14. Redox State in Atrial Fibrillation Pathogenesis and Relevant Therapeutic Approaches.
Antonopoulos AS; Goliopoulou A; Oikonomou E; Tsalamandris S; Papamikroulis GA; Lazaros G; Tsiamis E; Latsios G; Brili S; Papaioannou S; Gennimata V; Tousoulis D
Curr Med Chem; 2019; 26(5):765-779. PubMed ID: 28721830
[TBL] [Abstract][Full Text] [Related]
15. Non-antiarrhythmic drugs in atrial fibrillation: a review of non-antiarrhythmic agents in prevention of atrial fibrillation.
Lally JA; Gnall EM; Seltzer J; Kowey PR
J Cardiovasc Electrophysiol; 2007 Nov; 18(11):1222-8. PubMed ID: 17553070
[TBL] [Abstract][Full Text] [Related]
16. The potential role of thiazolidinediones in atrial fibrillation.
Liu T; Korantzopoulos P; Li G; Li J
Int J Cardiol; 2008 Aug; 128(1):129-30. PubMed ID: 17655946
[TBL] [Abstract][Full Text] [Related]
17. Perspectives and challenges of antioxidant therapy for atrial fibrillation.
Gasparova I; Kubatka P; Opatrilova R; Caprnda M; Filipova S; Rodrigo L; Malan L; Mozos I; Rabajdova M; Nosal V; Kobyliak N; Valentova V; Petrovic D; Adamek M; Kruzliak P
Naunyn Schmiedebergs Arch Pharmacol; 2017 Jan; 390(1):1-14. PubMed ID: 27900409
[TBL] [Abstract][Full Text] [Related]
18. Oxidative stress and inflammatory process in patients with atrial fibrillation: the role of left atrium distension.
Tousoulis D; Zisimos K; Antoniades C; Stefanadi E; Siasos G; Tsioufis C; Papageorgiou N; Vavouranakis E; Vlachopoulos C; Stefanadis C
Int J Cardiol; 2009 Aug; 136(3):258-62. PubMed ID: 18657327
[TBL] [Abstract][Full Text] [Related]
19. Fish oil not effective in preventing heart arrhythmias in some.
Mayo Clin Health Lett; 2006 Feb; 24(2):4. PubMed ID: 16639779
[No Abstract] [Full Text] [Related]
20. Anti-inflammatory effects of long-chain omega 3 fatty acids: potential benefits for atrial fibrillation.
Liu T; Li G
Med Hypotheses; 2005; 65(1):200-1. PubMed ID: 15893149
[No Abstract] [Full Text] [Related]
[Next] [New Search]
